Identification of GCP II Inhibitors Based on 4-Arylmethyl-3-(4- carboxyphenyl)-5-hydroxyisoxazole Scaffold

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|6|1|29-32

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.1, 2009-01, pp. : 29-32

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents

By Goel B.   Ram T.   Tyagi R.   Bansal E.   Kumar A.   Mukherjee D.   Sinha J.N.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 3, 1999-03 ,pp. : 265-269

Elsevier

Access to resources Recommend Favorite

Synthesis and Evaluation of 4-arylmethyl Curcumin Analgues as Potent Hsp90 Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 8, 2014-10 ,pp. : 993-999

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 374-385

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors

By  

Medicinal Chemistry, Vol. 11, Iss. 4, 2015-06 ,pp. : 342-353

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Novel HDAC Inhibitors by Structure-based Optimization of Cinnamic Hydroxamic Scaffold

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 5, 2015-06 ,pp. : 344-350

Bentham Science Publishers

Access to resources Recommend Favorite